Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hal Drakesmith, Professor of Iron Biology Genetics in IMD/MRC WIMM/TIDU, has been appointed as RDM’s first Cross-Cutting Research Theme Lead for Biomedical Metabolism, effective from January 2024.


Hal will lead various strands of work to capitalise on the strong and growing interest in metabolism around RDM/MSD, beginning with increasing connectivity amongst researchers in this area.


Hal comments, ‘Regulation of metabolism underpins health, goes awry in disease and offers potential therapeutic targets. This Theme brings together groups with an interest in metabolism, to share methods and expertise, and to develop new projects. Metabolism research is burgeoning in biomedicine and we aim to help it grow across RDM.’

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.